3-126988598-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 3P and 3B. PM2PP2BP4_ModerateBS1_Supporting

The NM_032242.4(PLXNA1):​c.5C>A​(p.Pro2Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 1,509,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000059 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0000081 ( 0 hom. )

Consequence

PLXNA1
NM_032242.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: -0.0750
Variant links:
Genes affected
PLXNA1 (HGNC:9099): (plexin A1) Predicted to enable semaphorin receptor activity. Predicted to be involved in several processes, including generation of neurons; regulation of GTPase activity; and regulation of cell shape. Predicted to act upstream of or within dichotomous subdivision of terminal units involved in salivary gland branching; neuron projection morphogenesis; and regulation of smooth muscle cell migration. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), PLXNA1. . Gene score misZ 3.4482 (greater than the threshold 3.09). Trascript score misZ 4.1522 (greater than threshold 3.09). GenCC has associacion of gene with Dworschak-Punetha neurodevelopmental syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.13111213).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0000591 (9/152262) while in subpopulation AFR AF= 0.000217 (9/41470). AF 95% confidence interval is 0.000113. There are 0 homozygotes in gnomad4. There are 2 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PLXNA1NM_032242.4 linkuse as main transcriptc.5C>A p.Pro2Gln missense_variant 2/32 ENST00000393409.3 NP_115618.3 Q9UIW2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PLXNA1ENST00000393409.3 linkuse as main transcriptc.5C>A p.Pro2Gln missense_variant 2/321 NM_032242.4 ENSP00000377061.2 Q9UIW2
PLXNA1ENST00000684469.1 linkuse as main transcriptc.5C>A p.Pro2Gln missense_variant 2/2 ENSP00000507976.1 A0A804HKL4

Frequencies

GnomAD3 genomes
AF:
0.0000591
AC:
9
AN:
152262
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000810
AC:
11
AN:
1357272
Hom.:
0
Cov.:
32
AF XY:
0.00000451
AC XY:
3
AN XY:
665850
show subpopulations
Gnomad4 AFR exome
AF:
0.000294
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000356
GnomAD4 genome
AF:
0.0000591
AC:
9
AN:
152262
Hom.:
0
Cov.:
34
AF XY:
0.0000269
AC XY:
2
AN XY:
74386
show subpopulations
Gnomad4 AFR
AF:
0.000217
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000793

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

PLXNA1-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 27, 2024The PLXNA1 c.5C>A variant is predicted to result in the amino acid substitution p.Pro2Gln. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Dworschak-Punetha neurodevelopmental syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingNew York Genome CenterJan 07, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
10
DANN
Benign
0.69
DEOGEN2
Benign
0.093
T
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.89
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.47
T
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.39
N
REVEL
Benign
0.023
Sift
Benign
0.049
D
Sift4G
Pathogenic
0.0
D
Vest4
0.20
MutPred
0.34
Loss of catalytic residue at P2 (P = 0.0016);
MVP
0.24
MPC
1.0
ClinPred
0.093
T
GERP RS
0.37
Varity_R
0.051
gMVP
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs576960383; hg19: chr3-126707441; API